RayzeBio Balance Sheet Health

Financial Health criteria checks 6/6

RayzeBio has a total shareholder equity of $575.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $603.5M and $28.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$540.17m
EquityUS$575.32m
Total liabilitiesUS$28.19m
Total assetsUS$603.51m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: RYZB's short term assets ($545.0M) exceed its short term liabilities ($17.1M).

Long Term Liabilities: RYZB's short term assets ($545.0M) exceed its long term liabilities ($11.1M).


Debt to Equity History and Analysis

Debt Level: RYZB is debt free.

Reducing Debt: RYZB has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RYZB has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: RYZB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 53.5% each year


Discover healthy companies